Consistent with these reports, RdB/IL12/DCN-treated mice exhibited significantly fewer Treg cells in both DLN and tumor tissues compared with mice treated with RdB, RdB/IL12 or RdB/DCN. This evidence concerns the gene DCN and neoplasm.